Related Experiment Video
Updated: May 17, 2026
08:16
Method for the Assessment of Effects of a Range of Wavelengths and Intensities of Red/near-infrared Light Therapy on Oxidative Stress In Vitro
Published on: March 21, 2015
Low-level laser therapy decreases renal interstitial fibrosis
Fabiana Aparecida Mayrink Oliveira1, Ana Carolina Meneghin Moraes, Amanda Povoa Paiva
1Division of Nephrology, Federal University of Juiz de Fora, Juiz de Fora (UFJF), Brazil.
Photomedicine and Laser Surgery
|November 9, 2012
Summary
Low-level laser therapy (LLLT) demonstrated a protective effect against renal interstitial fibrosis in a chronic kidney disease (CKD) model. This therapy reduced fibrosis and inflammatory markers, offering a potential new treatment for kidney disease.
Area of Science:
- Nephrology
- Biomedical Engineering
- Regenerative Medicine
Background:
- Chronic kidney disease (CKD) is characterized by progressive fibrosis, tubular atrophy, and kidney function loss.
- Effective therapies for CKD, including in kidney allografts, are currently limited.
- Interstitial fibrosis is a key pathological feature in various kidney diseases.
Purpose of the Study:
- To investigate the therapeutic potential of low-level laser therapy (LLLT) in mitigating renal interstitial fibrosis.
- To evaluate the effects of LLLT on a rat model of unilateral ureteral obstruction (UUO), a model for CKD.
Main Methods:
- LLLT (AlGaAs laser, 780 nm) was administered intraoperatively to one group of rats with UUO.
- Renal fibrosis was quantified using Sirius red staining after 14 days.
- Immunohistochemistry and RT-PCR assessed fibroblast markers (FSP-1, α-SMA) and pro-fibrotic/inflammatory gene expression (IL-6, MCP-1, TGF-β1, Smad3).
Main Results:
- LLLT treatment significantly reduced renal interstitial fibrosis in UUO rats compared to controls.
- The expression of inflammatory and pro-fibrotic markers was decreased in the LLLT-treated group.
- LLLT attenuated key cellular processes contributing to renal fibrosis.
Conclusions:
- LLLT exhibits a protective effect against renal interstitial fibrosis in the UUO model.
- LLLT may prevent tubular activation and transdifferentiation, crucial drivers of renal fibrosis.
- This study provides novel evidence for LLLT as a potential therapeutic strategy for fibrotic kidney diseases.
